Orinda Asset Management’s Gilead Sciences GILD Stock Holding History

Orinda Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,674	Closed	-$291K	–	52
2016 Q3	$291K	Buy	3,674 +2,105	+134%	+$171K	0.25%	40
2016 Q2	$144K	Hold	1,569	–	–	0.16%	74
2016 Q1	$144K	Buy	1,569 +386	+33%	+$34.8K	0.24%	44
2015 Q4	$120K	Sell	1,183 -24	-2%	-$2.5K	0.17%	72
2015 Q3	$119K	Buy	1,207 +162	+16%	+$18K	0.15%	73
2015 Q2	$122K	Sell	1,045 -182	-15%	-$19.9K	0.14%	77
2015 Q1	$120K	Buy	+1,227	New	+$125K	0.13%	91
2014 Q4	–	Sell	-1,430	Closed	-$152K	–	126
2014 Q3	$152K	Sell	1,430 -743	-34%	-$72.8K	0.25%	62
2014 Q2	$180K	Buy	+2,173	New	+$169K	0.35%	54
2013 Q4	–	Sell	-1,100	Closed	-$69K	–	135
2013 Q3	$69K	Buy	+1,100	New	+$65.7K	0.22%	126

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Orinda Asset Management's GILD Position: Q4 2016 in Review

Orinda Asset Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 3,674 shares — an estimated $291K sold.

Orinda Asset Management first reported a position in GILD in Q3 2013 and held it in 10 quarters. The position peaked at $291K in Q3 2016. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Orinda Asset Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Orinda Asset Management sold 3,674 Gilead Sciences shares in Q4 2016, an estimated $291K.
Orinda Asset Management first reported a position in Gilead Sciences in Q3 2013 and held it in 10 quarters.
Orinda Asset Management's Gilead Sciences position peaked at $291K in Q3 2016.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Orinda Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.